Opportunity Overview
Antioxidant Therapy for Smith-Lemli-Opitz Syndrone is a request for proposal (rfp) for government procurement in United States, issued by Health and Human Services, Department of and tracked by GlobalGov. It falls under Government Procurement. Responses are due by August 18, 2026. It was published on August 03, 2026. Full solicitation details, all dates, and related live opportunities are below.
Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.
Start FreeSolicitation Details
| Issuing agency | Health and Human Services, Department of |
|---|---|
| Country | United States |
| Category | Government Procurement |
| Published | August 03, 2026 |
| Procurement stage | Request for Proposal (RFP) |
| Response due | August 18, 2026 |
| Status | Open — accepting responses |
| Official source | View original notice |
| Last verified | August 12, 2026 |
Source: U.S. Government (SAM.gov) — public domain. GlobalGov is not affiliated with or endorsed by the United States Government.
Related Opportunities in United States
See every United States Government Procurement opportunity your competition is missing. Free for 14 days.
Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.
Start Free Trial — No Card RequiredFree 14-day trial · no card required
See who is already competing here →Get a free United States Government Procurement intelligence report in your inbox
A personalized report on United States Government Procurement opportunities, emailed in 5-10 minutes. One per month, no account needed.